Case report

Patients harboring EGFR mutation after primary resistance to crizotinib and response to EGFR-tyrosine kinase inhibitor

Wang WX, Jiang XW, Song ZB, Zhang YP

OncoTargets and Therapy 2016, 9:211-215

Published Date: 8 January 2016